487 related articles for article (PubMed ID: 27507214)
1. Blockade of FLT4 suppresses metastasis of melanoma cells by impaired lymphatic vessels.
Lee JY; Hong SH; Shin M; Heo HR; Jang IH
Biochem Biophys Res Commun; 2016 Sep; 478(2):733-8. PubMed ID: 27507214
[TBL] [Abstract][Full Text] [Related]
2. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
3. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.
Kodera Y; Katanasaka Y; Kitamura Y; Tsuda H; Nishio K; Tamura T; Koizumi F
Breast Cancer Res; 2011 Jun; 13(3):R66. PubMed ID: 21693010
[TBL] [Abstract][Full Text] [Related]
4. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
[TBL] [Abstract][Full Text] [Related]
5. Role of lymphangiogenesis and lymphangiogenic factors during pancreatic cancer progression and lymphatic spread.
Schneider M; Büchler P; Giese N; Giese T; Wilting J; Büchler MW; Friess H
Int J Oncol; 2006 Apr; 28(4):883-90. PubMed ID: 16525637
[TBL] [Abstract][Full Text] [Related]
6. Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model.
Maehana S; Nakamura M; Ogawa F; Imai R; Murakami R; Kojima F; Majima M; Kitasato H
Biomed Pharmacother; 2016 Dec; 84():660-665. PubMed ID: 27697638
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
[TBL] [Abstract][Full Text] [Related]
8. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO
Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000
[TBL] [Abstract][Full Text] [Related]
9. IGFBP7 functions as a potential lymphangiogenesis inducer in non-small cell lung carcinoma.
Zhao W; Wang J; Zhu B; Duan Y; Chen F; Nian W; Sun J; Zhang B; Tong Z; Chen Z
Oncol Rep; 2016 Mar; 35(3):1483-92. PubMed ID: 26706909
[TBL] [Abstract][Full Text] [Related]
10. Unexpected contribution of lymphatic vessels to promotion of distant metastatic tumor spread.
Ma Q; Dieterich LC; Ikenberg K; Bachmann SB; Mangana J; Proulx ST; Amann VC; Levesque MP; Dummer R; Baluk P; McDonald DM; Detmar M
Sci Adv; 2018 Aug; 4(8):eaat4758. PubMed ID: 30101193
[TBL] [Abstract][Full Text] [Related]
11. HHEX is a transcriptional regulator of the VEGFC/FLT4/PROX1 signaling axis during vascular development.
Gauvrit S; Villasenor A; Strilic B; Kitchen P; Collins MM; Marín-Juez R; Guenther S; Maischein HM; Fukuda N; Canham MA; Brickman JM; Bogue CW; Jayaraman PS; Stainier DYR
Nat Commun; 2018 Jul; 9(1):2704. PubMed ID: 30006544
[TBL] [Abstract][Full Text] [Related]
12. Suppression of lymphangiogenesis induced by Flt-4 antibody in gastric low-grade mucosa-associated lymphoid tissue lymphoma by Helicobacter heilmannii infection.
Nakamura M; Matsui H; Takahashi T; Ogawa S; Tamura R; Murayama SY; Takahashi S; Tsuchimoto K
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S1-6. PubMed ID: 20586849
[TBL] [Abstract][Full Text] [Related]
13. VEGFR3 tyrosine kinase inhibition aggravates cisplatin nephrotoxicity.
Black LM; Farrell ER; Barwinska D; Osis G; Zmijewska AA; Traylor AM; Esman SK; Bolisetty S; Whipple G; Kamocka MM; Winfree S; Spangler DR; Khan S; Zarjou A; El-Achkar TM; Agarwal A
Am J Physiol Renal Physiol; 2021 Dec; 321(6):F675-F688. PubMed ID: 34658261
[TBL] [Abstract][Full Text] [Related]
14. Endothelial nitric oxide synthase mediates lymphangiogenesis and lymphatic metastasis.
Lahdenranta J; Hagendoorn J; Padera TP; Hoshida T; Nelson G; Kashiwagi S; Jain RK; Fukumura D
Cancer Res; 2009 Apr; 69(7):2801-8. PubMed ID: 19318557
[TBL] [Abstract][Full Text] [Related]
15. Anti-VEGF-A therapy reduces lymphatic vessel density and expression of VEGFR-3 in an orthotopic breast tumor model.
Whitehurst B; Flister MJ; Bagaitkar J; Volk L; Bivens CM; Pickett B; Castro-Rivera E; Brekken RA; Gerard RD; Ran S
Int J Cancer; 2007 Nov; 121(10):2181-91. PubMed ID: 17597103
[TBL] [Abstract][Full Text] [Related]
16. Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer.
Yang H; Kim C; Kim MJ; Schwendener RA; Alitalo K; Heston W; Kim I; Kim WJ; Koh GY
Mol Cancer; 2011 Apr; 10():36. PubMed ID: 21481239
[TBL] [Abstract][Full Text] [Related]
17. The potential lymphangiogenic effects of hepatocyte growth factor/scatter factor in vitro and in vivo.
Jiang WG; Davies G; Martin TA; Parr C; Watkins G; Mansel RE; Mason MD
Int J Mol Med; 2005 Oct; 16(4):723-8. PubMed ID: 16142411
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor superfamily 15 promotes lymphatic metastasis via upregulation of vascular endothelial growth factor-C in a mouse model of lung cancer.
Qin T; Huang D; Liu Z; Zhang X; Jia Y; Xian CJ; Li K
Cancer Sci; 2018 Aug; 109(8):2469-2478. PubMed ID: 29890027
[TBL] [Abstract][Full Text] [Related]
19. Platelet interaction with lymphatics aggravates intestinal inflammation by suppressing lymphangiogenesis.
Sato H; Higashiyama M; Hozumi H; Sato S; Furuhashi H; Takajo T; Maruta K; Yasutake Y; Narimatsu K; Yoshikawa K; Kurihara C; Okada Y; Watanabe C; Komoto S; Tomita K; Nagao S; Miura S; Hokari R
Am J Physiol Gastrointest Liver Physiol; 2016 Aug; 311(2):G276-85. PubMed ID: 27313177
[TBL] [Abstract][Full Text] [Related]
20. Anlotinib suppresses lymphangiogenesis and lymphatic metastasis in lung adenocarcinoma through a process potentially involving VEGFR-3 signaling.
Qin T; Liu Z; Wang J; Xia J; Liu S; Jia Y; Liu H; Li K
Cancer Biol Med; 2020 Aug; 17(3):753-767. PubMed ID: 32944404
[No Abstract] [Full Text] [Related]
[Next] [New Search]
